Arcus Biosciences Statistics
NYSE: RCUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
24.52+0.24 (+0.99%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 24.52 -0.04%
Arcus Biosciences by the numbers
Arcus Biosciences has a market capitalization of $3.08 billion based on 125.77M shares outstanding. With trailing EPS of $-3.91, Arcus Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.3% below its 50-day average and 1.1% below its 200-day average.
Average daily trading volume is 1.32M shares, or about $32.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RCUS valuation vs. peer median
| Metric | RCUS | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.08B | $3.01B | +3% |
| Avg. volume | 1.32M | 2.26M | -42% |
Peer median across 8 companies: ARQT, ELVN, DYN, ZLAB, ACAD, MRVI, AMLX, PGEN.
Valuation
- Market cap
- $3.08B
- EPS (TTM)
- $-3.91
- Shares outstanding
- 125.77M
Price and trading
- Previous close
- 24.28
- Open
- 24.23
- Day range
- 23.90 – 24.83
- 52-week range
- 14.18 – 31.74
- 52-week change
- +74.91%
- Beta
- —
- Volume
- 1.60M
- Average volume
- 1.32M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 27, 2026
Additional statistics
- Market Cap
- 3.08B
- Forward Pe
- -7.51
- Eps
- -3.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.74
- Week52 Low
- 14.18
- Avg Volume
- 1.32M
- Shares Outstanding
- 125.77M
- Ma50
- 27.65
- Ma200
- 24.80
- Earnings Date
- Oct 27, 2026
- Pct From52w High
- -22.74%
- Pct From52w Low
- 72.92%